Changes in Beneficial Ownership · 4
Linde plc
LINNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1793812872.xml
Filing details
- Report period
- 2026-11-02
- Issuer
- LINDE PLC
- Issuer CIK
- 0001707925
- Trading symbol
- LIN
Reporting owner 1
- Name
- Bichara Guillermo
- Reporting owner CIK
- 0001629436
- Relationship
- Officer
- Officer title
- Exec VP & Chief Legal Officer
- Address
- C/O LINDE PLC, FORGE, 43 CHURCH STREET WEST, WOKING SURREY, UNITED KINGDOM, X0, GU216HT
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 2026-11-02 | M · Form 4 | 26,155 | A | 173.13 | 48,292.769 | D |
| Ordinary Shares | 2026-11-02 | F · Form 4 | 16,805[F1] | D | 518.685 | 31,487.769 | D |
| Ordinary Shares | 2026-11-02 | S · Form 4 | 9,350 | D | 518.911[F2] | 22,137.769 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- F · Form 4
- Securities delivered or withheld for exercise price or tax liability under Rule 16b-3
- S · Form 4
- Sale on the market or privately
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Ordinary Shares | 22,137.769 | D | |
| Ordinary Shares | 2,944.983 | I | 401(k) |
Table key
- D
- Direct
- I
- Indirect
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | 173.13 | 2026-11-02 | M · Form 4 | 26,155 | D | 0 | [F18] | 2030-03-09 | Ordinary Shares | 26,155 | 0 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Derivative holdings
| Security | Conversion / exercise price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Amount owned | Ownership |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | 154 | [F3] | 2028-02-27 | Ordinary Shares | 38,800 | 38,800 | D |
| Stock Options (right to buy) | 253.68 | [F4] | 2031-03-08 | Ordinary Shares | 20,975 | 20,975 | D |
| Stock Options (right to buy) | 465.29 | [F5] | 2034-03-07 | Ordinary Shares | 10,345 | 10,345 | D |
| Restricted Stock Units | [F6] | [F6] | [F6] | Ordinary Shares | 0 | 0 | D |
| Stock Options (right to buy) | 468.77 | [F7] | 2035-03-07 | Ordinary Shares | 11,326 | 11,326 | D |
| Restricted Stock Units | [F8] | [F9] | [F9] | Ordinary Shares | 1,830 | 1,830 | D |
| Stock Options (right to buy) | 354.14 | [F10] | 2033-03-07 | Ordinary Shares | 11,085 | 11,085 | D |
| Restricted Stock Units | [F11] | [F11] | [F11] | Ordinary Shares | 1,613 | 1,613 | D |
| Stock Options (right to buy) | 483.62 | [F12] | 2036-03-09 | Ordinary Shares | 14,917 | 14,917 | D |
| Restricted Stock Units | [F13] | [F13] | [F13] | Ordinary Shares | 1,570 | 1,570 | D |
| Stock Options (right to buy) | 118.71 | [F14] | 2027-02-28 | Ordinary Shares | 40,100 | 40,100 | D |
| Deferred Stock Units | [F15] | [F16] | [F16] | Ordinary Shares | 852.647 | 852.647 | D |
| Stock Options (right to buy) | 270.99 | [F17] | 2032-03-07 | Ordinary Shares | 13,280 | 13,280 | D |
| Stock Options (right to buy) | 253.68 | [F4] | 2031-03-08 | Ordinary Shares | 20,975 | 20,975 | D |
| Stock Options (right to buy) | 173.13 | [F18] | 2030-03-09 | Ordinary Shares | 26,155 | 26,155 | D |
| Restricted Stock Units | [F11] | [F11] | [F11] | Ordinary Shares | 1,613 | 1,613 | D |
Table key
- D
- Direct
Footnotes
- F1
- Ordinary shares withheld to cover exercise price and tax withholdings.↩ 1
- F2
- The price reported is the weighted average sale price. The sale prices ranged from 518.60 to 519.11. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.↩ 1
- F3
- This option vested over three years in three consecutive equal annual installments beginning on February 27, 2019.↩ 1
- F4
- This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.↩ 1↩ 2
- F5
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.↩ 1
- F6
- Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.↩ 1↩ 2↩ 3
- F7
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.↩ 1
- F8
- Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.↩ 1
- F9
- Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.↩ 1↩ 2
- F10
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.↩ 1
- F11
- Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.↩ 1↩ 2↩ 3↩ 4↩ 5↩ 6
- F12
- This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.↩ 1
- F13
- Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.↩ 1↩ 2↩ 3
- F14
- This option vested over three years in three consecutive equal annual installments beginning on February 28, 2018.↩ 1
- F15
- Conversion to Linde plc Ordinary Shares is on a one-to-one basis.↩ 1
- F16
- Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.↩ 1↩ 2
- F17
- This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.↩ 1
Signature 1
- Signed
- Anthony M. Pepper as attorney-in-fact
- Date
- 2026-11-03
Company context
Linde is a leading global industrial gases and engineering company with 2025 sales of $34 billion. We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain, decarbonize and protect our planet. Linde serves a variety of end markets such as chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining. Linde’s industrial gases and technologies are used in countless applications, enabling space exploration and launch technologies, delivering ultra-high-purity and specialty gases for semiconductor manufacturing, providing life-saving medical oxygen and enabling clean hydrogen production and carbon capture to reduce greenhouse gas emissions. Linde also delivers state-of-the-art gas processing solutions to support customer growth, efficiency improvements and emissions reductions.